Recombinant Human WFDC1 Protein，His

WFDC1, or WAP four-disulfide core domain protein 1, is a member of the WFDC protein family that plays a vital role in various biological processes, including immune response, inflammation, and tissue remodeling. Originally identified as a gene expressed in the epididymis, WFDC1 has garnered attention due to its potential involvement in cancer progression and metastasis, particularly in epithelial-derived tumors. It is believed to act as a suppressor of cancer cell invasion and migration, making it a target of interest for therapeutic strategies. Furthermore, its unique structural features, characterized by a four-disulfide core, suggest it could have distinct inhibitory functions on proteases, thereby impacting the extracellular matrix and cellular signaling pathways. Recent studies indicate that WFDC1 may also be implicated in the modulation of the tumor microenvironment, which further cements its relevance in cancer biology. Consequently, the recombinant expression of WFDC1 has become an essential focus for understanding its biological functions and therapeutic potential. Scientists aim to produce high-quality recombinant WFDC1 proteins to study their interactions and mechanisms of action in cellular models. This research not only enhances our understanding of WFDC1's role in tumor dynamics but also opens new avenues for developing targeted cancer therapies that exploit the protein's regulatory properties. Through these investigations, the aim is to delineate the relevance of WFDC1 in clinical contexts, potentially offering novel biomarkers or therapeutic targets for cancer diagnosis and treatment. Thus, studying the recombinant form of WFDC1 is crucial for uncovering its functions and developing innovative approaches in cancer therapeutics.